In a report released yesterday, Marie Thibault from BTIG reiterated a Buy rating on Masimo (MASI – Research Report), with a price target of ...

In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on RxSight (RXST – Research Report), with a price target of ...

The S&P 500 may be due for a short-term bounce after its pullback from last week's record highs — but don't expect it to last ...

BTIG upgraded Snowflake Inc (NYSE:SNOW) to "Buy" from "Neutral" and introduced a $220 price target on improving demand trends and potential AI-driven growth.

Marine Systems, a key segment for GD, continues to face margin pressure despite robust sales growth, as supply chain challenges and rising labour costs weigh on profitability. Additionally, BTIG ...

Investors attending the conference wishing to schedule a meeting are encouraged to contact BTIG to schedule. Event: BTIG’s MedTech, Digital Health, Life Science & Diagnostic Tools Conference 2025 ...

On Tuesday, BTIG analyst Thomas Catherwood maintained a Neutral rating on shares of Kilroy Realty Corporation (NYSE:KRC), following the company's release of its fourth-quarter 2024 financial results.

Oncocyte will host one-on-one meetings with interested investors. Investors attending the conference wishing to schedule a meeting are encouraged to contact BTIG to schedule.

announced today that it will participate in the BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference, on Wednesday, February 12th. Rohit Ramchandani, CFO ...

“This partnership addresses the growing demand among institutional traders for advanced, centralised technology that enables seamless access to deep liquidity and high-quality execution,” said the ...